• Products
    • Ascent (For LC GC MS)
    • ARQ (For PCR)
  • Company
    • About Us
    • Careers
  • Resources
  • Contact
  • Get a demo
B-169 Beta-hydroxybutyrate/acetoacetate Ratio as Indicator for Mitochondrial Diseases Utilizing a Novel LC-MS/MS Based Ketone Body Panel

B-169 Beta-hydroxybutyrate/acetoacetate Ratio as Indicator for Mitochondrial Diseases Utilizing a Novel LC-MS/MS Based Ketone Body Panel

by Lucy Olmstead | Jun 16, 2025 | Uncategorized

Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry Analysis of Urinary Oligosaccharides and Glycoamino Acids for the Diagnosis of Mucopolysaccharidosis and Glycoproteinosis

Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry Analysis of Urinary Oligosaccharides and Glycoamino Acids for the Diagnosis of Mucopolysaccharidosis and Glycoproteinosis

by Lucy Olmstead | Jun 16, 2025 | Uncategorized

Recent Posts

  • Randall Julian to Teach R Programming for Mass Spectrometry at the Clinical & Translational Omics Symposium
  • Indigo BioAutomation at MSACL 2025
  • What We’re Bringing to ADLM 2025: Innovation, Insight, and What’s Next
  • Automated Detection and Re-Analysis of Over-Range and Saturating Samples
  • Development and Validation of a Comprehensive Dilute-and-Shoot LC-MS/MS Method: Qualitative Confirmation of 113 Drugs in Urine

Recent Comments

No comments to show.
  • Products
    • ASCENT
    • ARQ
  • Company
    • About Us
    • Careers
  • Resources
  • Contact
  • Request a demo
  • Products
    • ASCENT
    • ARQ
  • Company
    • About Us
    • Careers
  • Resources
  • Contact
  • Request a demo
bsi assurance
CLSI Logo

© Indigo BioAutomation 2026 | Site Map | Privacy Policy | Terms of Use



385 City Center Drive, Suite 200 | Carmel, IN 46032
[email protected] | 317.493.2400

© Indigo BioAutomation 2025 | Site Map | Privacy Policy | Terms of Use